Using our mobile app? Be sure to check for any new app updates to receive any enhancements.
Logo

Get Healthy!

Results for search "Clinical Trials".

Health News Results - 87

MONDAY, June 17, 2019 (HealthDay News) -- Treatment with blood pressure medication can improve blood flow to a key brain region in people with Alzheimer's disease, a small clinical trial has found.

Researchers stressed that they do not know whether the brain finding can translate into any benefits for patients. But future studies should look into that possibility, they said.

MONDAY, June 10, 2019 (HealthDay News) -- A two-year delay in the onset of type 1 diabetes could make a big difference for people with the disease. And researchers say a new drug may make that postponement possible.

Researchers gave the drug teplizumab or a placebo to a small group of people who were nearly certain to develop type 1 diabetes, based on genetics and certain symptoms. Th...

SUNDAY, June 2, 2019 (HealthDay News) -- Cutting-edge prostate cancer drugs that help extend life in the toughest cases might also be useful in fighting less aggressive tumors, two new clinical trials suggest.

Two drugs that interfere with cancer's ability to use testosterone for fuel, apalutamide (Erleada) and enzalutamide (Xtandi), are already approved fo...

FRIDAY, May 10, 2019 (HealthDay News) -- Medical marijuana extracts appear to help children with autism, reducing their disruptive behavior while improving their social responsiveness, a new Israeli clinical trial reports.

Kids treated with either a whole-plant cannabis extract or a pure combination of cannabidiol (CBD) and THC experienced a significant improvement in their symptoms, co...

WEDNESDAY, May 1, 2019 (HealthDay News) -- Hormone-based treatment might improve social function in people with autism, a pair of new clinical trials suggests.

Both focused on vasopressin, a hormone that has been implicated in the brain's ability to manage social behavior.

In the first trial, vasopressin given as a nasal spray helped improve social responsiveness in kids wit...

THURSDAY, April 25, 2019 (HealthDay News) -- The idea behind immunotherapy for peanut allergy is appealing in its simplicity: Ask a patient to eat tiny amounts of peanut every day, and over time their immune system will become desensitized to it.

Unfortunately, this cure might be doing more harm than the allergy itself, a new evidence review suggests.

People who undergo immunoth...

THURSDAY, April 18, 2019 (HealthDay News) -- Researchers say an experimental stroke drug prevented blood clots without the typical side effect of blood thinners: increased bleeding risk.

Bleeding is a common and potentially dangerous side effect of current anti-clotting drugs used to treat stroke patients. But the new findings suggest that the antiplatelet drug, called ACT017, may be ...

MONDAY, April 15, 2019 (HealthDay News) -- Danish researchers have sniffed out a potential new weapon to fight armpit odor.

It's zinc oxide, or ZnO. The strategy was inspired by hospital wound care. Because putting zinc oxide on open surgical wounds reduces corynebacteria and the bad smell it creates, researchers thought it might also make an effective deodorant.

The study a...

TUESDAY, April 9, 2019 (HealthDay News) -- A new method of brewing a cancer vaccine inside a patient's tumor could harness the power of the immune system to destroy the disease, researchers report.

Immune stimulants are injected directly into a tumor, which teaches the immune system to recognize and destroy all similar cancer cells throughout the body, said senior researcher Dr...

THURSDAY, March 28, 2019 (HealthDay News) -- Blood vessels created in the lab can successfully turn into "living tissue" in patients on dialysis for advanced kidney disease, a new study suggests.

The results come from just 13 patients in an early-phase trial. But researchers said they are a sign that the engineered tissue might eventually offer new treatment options for patients with da...

FRIDAY, March 15, 2019 (HealthDay News) -- Precious few treatment guidelines for heart patients are supported by the best scientific evidence, a new study shows.

Less than one in 10 recommendations are based on results from multiple randomized controlled trials (considered the "gold standard"), and that percentage has actually dropped in the past decade, the researchers reported.

...

THURSDAY, March 14, 2019 (HealthDay News) -- People whose high cholesterol is resistant to treatment with statin drugs may soon have a new treatment option.

This new class of drugs helps block synthesis of artery-clogging cholesterol, researchers explained. The drugs target an enzyme called ATP citrate lyase (ACL), part of the production pathway for "bad" LDL cholesterol in the body.

TUESDAY, Feb. 26, 2019 (HealthDay News) -- For people with the deadly skin cancer melanoma, one dose of the drug Keytruda before surgery might stop the cancer in its tracks, according to a groundbreaking new study.

Keytruda (pembrolizumab) is a PD-1 inhibitor, an immunotherapy drug that triggers the body's immune response to attack cancer cells. According to results of this study, the...

THURSDAY, Feb. 21, 2019 (HealthDay News) -- People who are paid to take part in research may be more likely to lie about their eligibility than those who aren't paid, a new study finds.

It included nearly 2,300 people who were surveyed on whether they're received a recent flu shot. One group of participants was told that their eligibility to take part in the survey didn't depend on wh...

WEDNESDAY, Feb. 20, 2019 (HealthDay News) -- An experimental drug has shown promise in extending the lives of women suffering from a particularly aggressive and deadly type of breast cancer, according to the results of a phase 2 trial.

Right now, the standard treatment of chemotherapy for metastatic triple-negative breast cancer has not been very effective. That might change with the...

FRIDAY, Feb. 1, 2019 (HealthDay News) -- Instead of popping a painkiller, a little mindful yoga might go a long way toward easing longstanding pain, a new study suggests.

The review of 21 clinical trials involving nearly 2,000 people looked at the effects of two drug-free options for chronic pain: cognitive behavioral therapy (CBT) and a program called mindfulness-based stress reducti...

FRIDAY, Feb. 1, 2019 (HealthDay News) -- Cholesterol-lowering statins are already known to help cut heart risks for seniors and the middle-aged. Now, research confirms the meds can also help people aged 75 and older.

"Statin therapy has been shown to prevent cardiovascular disease in a wide range of people, but there has been uncertainty about its efficacy and safety among older peop...

TUESDAY, Jan. 15, 2019 (HealthDay News) -- A stem cell transplant may help some people with multiple sclerosis (MS) when standard drugs fail, a new clinical trial finds.

The study focused on 110 patients with aggressive cases of MS: Their symptoms had flared up at least twice in the past year despite taking standard medication, and they'd already tried an average of three of those dru...

MONDAY, Nov. 19, 2018 (HealthDay News) -- Drug approvals for adults often require future studies in children, but many of these studies are never completed, a new analysis finds.

"More than 50 percent of all drugs approved by the FDA lack information on how to safely and effectively use the drug in children," said study author Dr. Florence Bourgeois, from the Pediatric Therapeutics an...

WEDNESDAY, Nov. 14, 2018 (HealthDay News) -- People with celiac disease must follow a very restrictive diet, but an experimental vaccine may offer many of them the freedom to eat more normally.

Celiac disease is an autoimmune disorder. If someone with the disease eats gluten -- a protein found in wheat, barley and rye -- it can damage the small intestine.

The vaccine, dubbe...

WEDNESDAY, Nov. 7, 2018 (HealthDay News) -- Untreatable, antibiotic-resistant gonorrhea has become a chilling prospect in the United States, raising concerns that people might someday have to live with the sexually transmitted bacteria.

But now there's reason for hope. A newly developed antibiotic pill has proven effective against gonorrhea in early clinical trials.

Zoliflod...

THURSDAY, Nov.1, 2018 (HealthDay News) -- The first Food and Drug Administration-approved drug containing an ingredient derived from the marijuana plant went on sale Thursday in the United States.

Epidiolex is a twice-daily oral solution -- a cannabidiol, or CBD liquid -- made by Britain-based GW Pharmaceuticals. It is approved for use in patients 2 years old and older with two types ...

FRIDAY, Oct. 26, 2018 (HealthDay News) -- An experimental vaginal ring meant to prevent pregnancy and HIV looks safe, according to an early stage study.

The dual-purpose ring releases the antiretroviral drug dapivirine and the contraceptive hormone levonorgestrel, said researchers led by Dr. Sharon Achilles, of the University of Pittsburgh School of Medicine.

"We are very e...

THURSDAY, Oct. 25, 2018 (HealthDay News) -- A new gene therapy might help improve motor symptoms in people with Parkinson's disease who aren't responding to other therapies, an early study has found.

"This is not a cure of Parkinson's disease," said James Beck, chief scientific officer of the Parkinson's Foundation. "This is a potentially good treatment for symptom control. It provid...

THURSDAY, Oct. 18, 2018 (HealthDay News) -- In what researchers are calling a "breakthrough," two preliminary trials have found that either of two triple-drug regimens could potentially benefit 90 percent of people with cystic fibrosis.

The trials were short-term, finding that the drug combinations improved adult patients' lung function over four weeks. But experts said they were opti...

MONDAY, Oct. 1, 2018 (HealthDay News) -- A personalized vaccine held an aggressive group of cancers in check among more than half of patients who received it in a small, preliminary trial, researchers report.

HER2-positive cancers are cancers that have too much of the HER2 protein on their surface. In that setting, a cancer can grow rapidly and be more likely to spread to other areas ...

WEDNESDAY, Sept. 26, 2018 (HealthDay News) -- A combination of two HIV-fighting antibodies can suppress the virus in some patients, even after they stop standard drugs, a preliminary trial has shown.

Researchers found that among 11 HIV patients given the antibody combo, nine maintained complete suppression of the virus after going off their medication regimen. The benefit typically la...

TUESDAY, Sept. 18, 2018 (HealthDay News) -- Thousands of Americans struggling with chronic obstructive pulmonary disease (COPD) may have a new treatment option to help them breathe easier.

COPD, which is often linked to smoking, is a progressive deterioration of lung function that involves a combination of bronchitis and emphysema symptoms. It's the third leading cause of death in th...

THURSDAY, Sept. 6, 2018 (HealthDay News) -- An experimental single-dose flu drug shows promise as a new way to alleviate the misery of influenza, researchers say.

The drug -- called baloxavir -- worked better than no treatment in one phase of a new study. The study also found it as effective as the current standard drug, oseltamivir (Tamiflu), at controlling symptoms such as coughing,...

WEDNESDAY, Aug. 29, 2018 (HealthDay News) -- A drug that has long been used in Japan for asthma may slow down brain shrinkage in people with progressive multiple sclerosis, a preliminary trial has found.

The study, published Aug. 30 in the New England Journal of Medicine, tested an oral drug called ibudilast. It is not approved in the United States, but has been used for years ...

FRIDAY, Aug. 17, 2018 (HealthDay News) -- Differences in survival rates between rural and urban cancer patients may be due to the kind of care they receive, a review of cancer clinical trials contends.

Research has shown that cancer patients in rural areas have lower survival rates than those in urban areas. For example, cancer death rates between 2011 and 2015 were 180 per 100,000 pe...

THURSDAY, Aug. 16, 2018 (HealthDay News) -- HIV, the virus that causes AIDS, is typically a manageable infection, but medications that keep the virus at bay don't work for everyone. Now, researchers have developed a new medication to help them.

The U.S. Food and Drug Administration approved the drug -- ibalizumab (Trogarzo) -- in March. Phase 3 trial results were published in the Aug...

WEDNESDAY, Aug. 15, 2018 (HealthDay News) -- For women with advanced breast cancer who carry the BRCA1 and BRCA2 gene mutations, an experimental drug could improve survival, a new study suggests.

The BRCA mutations are linked with a greater risk for aggressive breast and ovarian cancer. The drug, talazoparib, works by blocking an enzyme called poly ADP ribose polymerase (PARP), thus p...

TUESDAY, Aug. 14, 2018 (HealthDay News) -- A low-dose three-in-one combination pill controls blood pressure more effectively than the regular medications people take, according to data from a new clinical trial.

About 70 percent of patients with mild-to-moderate high blood pressure who were given the "Triple Pill" reached their target blood pressure goal of 140/90 or less within six m...

WEDNESDAY, July 18, 2018 (HealthDay News) -- An FDA-approved supplement reduces episodes of severe pain in people with sickle cell disease, a new clinical trial shows.

Endari, a medicine-grade version of the dietary supplement L-glutamine, reduced sickle cell patients' number of acute pain crises by 25 percent compared with a placebo, the researchers found.

In addition, the ...

WEDNESDAY, June 27, 2018 (HealthDay News) -- Men with localized high-risk prostate cancer can slow its spread by using a cancer drug that's already on the market, a new clinical trial shows.

The targeted drug enzalutamide (Xtandi) reduced by 71 percent these men's risk of either dying from their prostate cancer or having the cancer spread to other organs, compared against a placebo. T...

MONDAY, June 25, 2018 (HealthDay News) -- In a regulatory first, the U.S. Food and Drug Administration on Monday said it had approved a drug with an ingredient derived from the marijuana plant.

In a statement, the agency said it had "approved Epidiolex [cannabidiol, or CBD] oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastau...

THURSDAY, June 21, 2018 (HealthDay News) -- Could a vaccine from the early 1900s be the key to preventing serious diabetes complications? Maybe, say researchers from Harvard University and Massachusetts General Hospital.

A little more than three years after getting two tuberculosis shots four weeks apart, about 50 people with type 1 diabetes saw their long-term average blood sugar le...

WEDNESDAY, June 6, 2018 (HealthDay News) -- An experimental HIV vaccine protected animals from dozens of strains of HIV. And a human trial of the vaccine is expected to begin in the second half of 2019, according to U.S. researchers.

The vaccine targets a vulnerable site on HIV -- the virus that causes AIDS -- and triggered antibody production in mice, guinea pigs and monkeys, accordi...

MONDAY, June 4, 2018 (HealthDay News) -- Many people with advanced kidney cancer might not need to have their kidneys removed during treatment, something that until now has been standard practice.

Patients who only received a targeted drug for their kidney cancer survived just as well as those who had their cancerous organ removed before drug therapy, according to a new clinical trial...

SUNDAY, June 3, 2018 (HealthDay News) -- A cancer drug that boosts the immune system outperforms chemotherapy in fighting advanced lung cancer, a new trial shows.

Keytruda (pembrolizumab) extended life four to eight months longer than chemotherapy in lung cancer patients whose immune systems had been duped by their cancer cells.

"This trial shows ...

SUNDAY, June 3, 2018 (HealthDay News) -- Children suffering from rhabdomyosarcoma, a rare cancer of the muscle tissue, may have better chances for a cure if they have extended chemotherapy, a new study finds.

In a phase 3 clinical trial, adding six months of low-dose maintenance chemotherapy after initial treatment extended the five-year survival rate from...

FRIDAY, June 1, 2018 (HealthDay News) -- Black men with advanced prostate cancer who get chemotherapy may live longer than white men, a new study suggests.

Data from nine trials including more than 8,000 men with advanced prostate cancer showed that survival for black men was initially the same as for white men -- an average of 21 months.

But after taking into account othe...

FRIDAY, May 18, 2018 (HealthDay News) -- Chiropractic care can help ease low back pain when added to a comprehensive treatment plan, a new clinical trial has found.

Active-duty military personnel reported having fewer back problems when they visited a chiropractor along with receiving usual medical care, the researchers said.

"This study provides the strongest evidence to da...

WEDNESDAY, May 16, 2018 (HealthDay News) -- Less appears to be more when it comes to treating epilepsy with the marijuana extract cannabidiol, a new clinical trial suggests.

Patients taking a 10-milligram (mg) daily dose of pharmaceutical grade cannabidiol (CBD) experienced nearly as great a reduction in seizures as patients on 20 mg, and with fewer side effects, said lead researcher ...

TUESDAY, May 1, 2018 (HealthDay News) -- People suffering from post-traumatic stress disorder (PTSD) might find some relief by using the popular party drug ecstasy, a small study suggests.

Technically, this synthetic drug is called 3,4-methylenedioxy-methamphetamine (MDMA) and it alters mood and perception. When tried with 26 veterans and first responders with PTSD, it helped many of ...

WEDNESDAY, April 4, 2018 (HealthDay News) -- A new stem cell transplant might help preserve or even restore vision being lost to the dry form of age-related macular degeneration, a new pilot clinical trial has shown.

In the experimental therapy, a specially engineered sheet of stem cells is transplanted into the back wall of the eye to replace a layer of cells destroyed by age-related...

WEDNESDAY, March 28, 2018 (HealthDay News) -- Stigma surrounding Alzheimer's disease may discourage Americans from learning about their risk and from joining clinical trials for potential new treatments, a small survey reveals.

"We found that concerns about discrimination and overly harsh judgments about the severity of symptoms were most prevalent," lead researcher Shana Stites said ...

THURSDAY, Feb. 22, 2018 (HealthDay News) -- More than one-third of early clinical trials exaggerate positive findings and may give patients false hope, a new study suggests.

Researchers reviewed data from 930 clinical trials published in 10 leading medical journals between early 2007 and mid-2015. The investigators found that a significant number of early trials reported effects that ...

WEDNESDAY, Feb. 21, 2018 (HealthDay News) -- Good old aspirin is just as effective as newer, expensive drugs at preventing blood clots after hip or knee replacement, a new clinical trial suggests.

Researchers said the findings could change some doctors' prescribing habits.

After knee or hip replacement surgery, there's a risk of blood clots in the legs or lungs. So it's rout...

Show All Health News Results

Wellness Library Results - 1

It pays to have back-up when serious illness strikes, judging from the legions of patients who turn to Web merchants selling customized medical information about specialists, clinical trials, and treatments. But the true value of such services, which cost $75 to $550 or more, isn't clear. Among the believers is Edward Barr, 71, a food manufacturer in Toronto, Ontario. Lying in intensive care after...

Show All Wellness Library Results